Drug Transporter (DT) Information
General Information and Variability Data of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0111 | ||||
Gene Name | SLC16A7 | ||||
Protein Name | Monocarboxylate transporter 2 | ||||
Synonyms | Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
DT Family | Major Facilitator Superfamily (MFS) | ||||
Monocarboxylate Transporter (MCT) Family | |||||
Tissue Specificity | Detected in heart and in blood lymphocytes and monocytes (at protein level). High expression in testis, moderate to low in spleen, heart, kidney, pancreas, skeletal muscle, brain and Leukocyte. Restricted expression in normal tissues, but widely expressed in cancer cells. | ||||
Function | This transporter functions as high-affinity pyruvate transporter, and this proton-coupled monocarboxylate transporter can catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate. | ||||
Disease(s) | Epilepsy [ICD-11: 8A6Z] | ||||
Obesity [ICD-11: 5B81] | |||||
Pain [ICD-11: MG30-MG7Z] | |||||
Heart attack [ICD-11: BA41.Z] | |||||
Genetic Polymorphisms & Epigenetic Regulations of DT | |||||
Species-, Tissue- and Disease-specific Protein Abundances of DT | |||||
Exogenous Factor Altering DT Activity | |||||
Approved Drug(s) Transported by This DT | Atorvastatin | Drug Info | Hyperlipidaemia [ICD-11: 5C8Z] | Approved | [1] |
Ibuprofen | Drug Info | Pain [ICD-11: MG30-MG7Z] | Approved | [1] | |
Milchsaure | Drug Info | Metabolic acidosis [ICD-11: 5C73] | Approved | [2] | |
Propicillin | Drug Info | Streptococcus bacterial infections [ICD-11: 1C41] | Approved | [1] | |
Quercetin | Drug Info | Coronary artery disease [ICD-11: BA6Z] | Approved | [1] | |
Salicylic acid | Drug Info | Dermatitis [ICD-11: EA80-EA8Z] | Approved | [3] | |
Valproic Acid | Drug Info | Epilepsy [ICD-11: 8A6Z] | Approved | [1] | |
Endogenous Substrate(s) | Monocarboxylates; Gamma-hydroxybutyrate | ||||
Drug-DT Affinity Assessed by Cell Line | |||||
Drug(s) with Drug-DT Affinity Data | Milchsaure | Drug Info | Oocytes-MCT2 | Km = 6.5 microM | [4] |
References | |||||
1 | Monocarboxylate Transporters in Drug Disposition: Role in the Toxicokinetics and Toxicodynamics of the Drug of Abuse GHB. | ||||
2 | Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem J. 1999 Aug 1;341 ( Pt 3):529-35. | ||||
3 | Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy. Clin Transl Sci. 2018 Jul;11(4):352-364. | ||||
4 | Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem. 1998 Oct 30;273(44):28959-65. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.